Search

Author/Creator Phipps, Alex

1. A Consideration of Fixed Dosing Versus Body Size‐Based Dosing Strategies for Chimeric Antigen Receptor T‐Cell Therapies. Issue 10 (12th September 2022)

Authors:
He, Jimmy Zhijian; Wang, Hechuan; Lim, KyoungSoo; Ren, Song; Rollins, Fred; Vallaster, Markus; Wong, Ryan; Stebbings, Richard; Standifer, Nathan; Keefe, Robert; Phipps, Alex; Gibbs, Megan
Journal:
Clinical pharmacology in drug development
Issue:
Volume 11:Issue 10(2022)
Page Start:
1130
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Absorption, distribution, metabolism and excretion (ADME) of the ALK inhibitor alectinib: results from an absolute bioavailability and mass balance study in healthy subjects. (4th March 2017)

Authors:
Morcos, Peter N.; Yu, Li; Bogman, Katrijn; Sato, Mika; Katsuki, Hisakazu; Kawashima, Kosuke; Moore, David J; Whayman, Matt; Nieforth, Keith; Heinig, Katja; Guerini, Elena; Muri, Dieter; Martin-Facklam, Meret; Phipps, Alex
Journal:
Xenobiotica
Issue:
Volume 47:Number 3(2017)
Page Start:
217
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Best Practices to Maximize the Use and Reuse of Quantitative and Systems Pharmacology Models: Recommendations From the United Kingdom Quantitative and Systems Pharmacology Network. (22nd March 2019)

Authors:
Cucurull‐Sanchez, Lourdes; Chappell, Michael J.; Chelliah, Vijayalakshmi; Amy Cheung, S. Y.; Derks, Gianne; Penney, Mark; Phipps, Alex; Malik‐Sheriff, Rahuman S.; Timmis, Jon; Tindall, Marcus J.; van der Graaf, Piet H.; Vicini, Paolo; Yates, James W. T.
Journal:
CPT: pharmacometrics & systems pharmacology
Issue:
Volume 8:Number 5(2019)
Page Start:
259
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Clinical Drug–Drug Interactions Through Cytochrome P450 3A (CYP3A) for the Selective ALK Inhibitor Alectinib. Issue 3 (28th September 2016)

Authors:
Morcos, Peter N.; Cleary, Yumi; Guerini, Elena; Dall, Georgina; Bogman, Katrijn; De Petris, Luigi; Viteri, Santiago; Bordogna, Walter; Yu, Li; Martin‐Facklam, Meret; Phipps, Alex
Journal:
Clinical pharmacology in drug development
Issue:
Volume 6:Issue 3(2017)
Page Start:
280
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Effect of Food and Esomeprazole on the Pharmacokinetics of Alectinib, a Highly Selective ALK Inhibitor, in Healthy Subjects. Issue 4 (28th September 2016)

Authors:
Morcos, Peter N.; Guerini, Elena; Parrott, Neil; Dall, Georgina; Blotner, Steven; Bogman, Katrijn; Sturm, Carolina; Balas, Bogdana; Martin‐Facklam, Meret; Phipps, Alex
Journal:
Clinical pharmacology in drug development
Issue:
Volume 6:Issue 4(2017)
Page Start:
388
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Effect of the Wetting Agent Sodium Lauryl Sulfate on the Pharmacokinetics of Alectinib: Results From a Bioequivalence Study in Healthy Subjects. Issue 3 (3rd October 2016)

Authors:
Morcos, Peter N.; Parrott, Neil; Banken, Ludger; Timpe, Carsten; Lindenberg, Marc; Guerini, Elena; Dall, Georgina; Bogman, Katrijn; Sturm, Carolina; Zeaiter, Ali; Martin‐Facklam, Meret; Phipps, Alex
Journal:
Clinical pharmacology in drug development
Issue:
Volume 6:Issue 3(2017)
Page Start:
266
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Model‐Based Assessments of CYP‐Mediated Drug–Drug Interaction Risk of Alectinib: Physiologically Based Pharmacokinetic Modeling Supported Clinical Development. Issue 3 (27th December 2017)

Authors:
Cleary, Yumi; Gertz, Michael; Morcos, Peter N.; Yu, Li; Youdim, Kuresh; Phipps, Alex; Fowler, Stephen; Parrott, Neil
Journal:
Clinical pharmacology & therapeutics
Issue:
Volume 104:Issue 3(2018)
Page Start:
505
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗